好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Muscle Disease: Basic Studies

Wednesday 04/16/08
03:45 PM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Muscle Disease/Neuromuscular Junction
No CME available
Event Timeline
03:45 PM - 05:00 PM Abstract 001 - A Gene Therapy Approach To Treat Cardiomyopathy in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD)
03:45 PM - 05:00 PM Abstract 002 - Targeting the Dystrophia Myotonica Protein Kinase (DMPK) Gene To Reduce RNA Toxicity
03:45 PM - 05:00 PM Abstract 003 - Further Investigation of the Myostatin System in Human Skeletal Muscle Disease
03:45 PM - 05:00 PM Abstract 004 - Long-Term Enhancement of Skeletal Muscle Mass and Strength by Single Gene Administration of Myostatin Inhibitiors
03:45 PM - 05:00 PM Abstract 005 - Imatinib Attenuated Skeletal Muscle Dystrophy in [italic]mdx[/italic] Mice
Faculty Disclosures
George Karpati, MD No disclosure on file
John T. Kissel, MD, FAAN Dr. Kissel has nothing to disclose.
Jerry R. Mendell, MD, FAAN Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Richard M. Ransohoff, MD Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care.
Zarife Sahenk, MD, PhD, FAAN Dr. Sahenk has nothing to disclose.
Steven A. Greenberg, MD Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abcuro, Inc.. Dr. Greenberg has stock in Abcuro. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care.
Lan Zhou, MD, PhD The institution of Dr. Zhou has received research support from NIH.
Michael Sinnreich, MD, PhD Prof. Sinnreich has nothing to disclose.
Amelie Nadeau, MD No disclosure on file
No disclosure on file
Brian K. Kaspar, PhD No disclosure on file
K. Reed Clark, PhD No disclosure on file
Louise R. Rodino-Klapac Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care.
Clifford J. Beall, PhD No disclosure on file
Clotilde Balucani, MD, PhD Dr. Balucani has nothing to disclose.
Rochelle T. Sweis, DO No disclosure on file
Preston Douglas, MD No disclosure on file
Luka Vlahovic, MD Dr. Vlahovic has nothing to disclose.
R Khan No disclosure on file